Biomodal, formerly known as Cambridge Epigenetix, is a brand that offers innovative technology and solutions for exploring biology in every mode. With their capture genetic and epigenetic information simultaneously, they provide a single workflow that allows for a better understanding of normal and disease biology. Unlike current technologies, Biomodal's approach can accurately measure multiple modalities in less time, using just 10ng of DNA.

Their combined epigenetic and genetic analysis in a single sequencing run enables access to critical information from DNA samples, making it a valuable tool in cancer research, aging studies, population genetics, non-invasive prenatal testing, neurodegenerative disease research, and precision medicine. Biomodal also introduces the duet multiomics solution +modC, which transforms multiple workflow setups into a single multiomic solution, providing access to both genetic and epigenetic sequence data from one sample. With their team's culture of curiosity, Biomodal leads the way in exploring uncharted territories.

Stay informed about their latest developments and meet the experts driving their growth in the field. Visit their website to learn more about their exceptional science and get in touch to explore how Biomodal can revolutionize your research